Achieving optimal long-term glycemic control as well as reducing the risk of cardiovascular (CV), neurodegenerative diseases, and mortality continues to be a challenge for a significant portion of patients with type 2 diabetes (T2DM) and type 1 diabetes (T1DM) worldwide [8,9,10,11,12,13,14]
CSCs are a subpopulation of tumor cells with the capability to self-renew and differentiate, which drives tumor progression and metastasis
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current pharmaceutical design 17.16 (2011): 1612-1632
Then the dose can be reduced to 1 injection every 2 weeks for maintenance.
It achieves high purity and stability, making it suitable for incorporation into various skincare products